SAfety And FEasibility of Angiontensin Receptor Neprilysin Inhibitor in real- world Patients with Acute decompensaTed Heart failure
Anno:
2023
Background: To determine the safety and feasibility of in-hospital sacubitril/valsartan initiation after clinical stabilization in patients with acute decompensated heart failure (ADHF) and reduced ejection fraction (EF). Methods: This retrospective, multicenter observational study included patients admitted for ADHF in 2 Italian centers between February 2017 and January 2022. Feasibility…